Anti-Kv1.4 Antibody-Associated Myocarditis Refractory to Maintenance Immunosuppressive Therapy: A Case Report

Clicks: 3
ID: 338200
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #406 of 408 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 408 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Anti-Kv1.4 antibody-associated myocarditis is an extremely rare condition and its optimal long-term management remains unclear. Case Summary A 66-year-old woman presented with myasthenia gravis-like symptoms, marked creatine kinase elevation, leukopenia, and hypogammaglobulinaemia. She developed acute myocarditis with ventricular arrhythmias and a reduced left ventricular ejection fraction. Intravenous immunoglobulin and corticosteroid therapy resulted in rapid clinical and cardiac improvement. During cautious tapering of oral prednisolone, she was readmitted with febrile neutropenia and subsequently developed progressive ventricular dysfunction and cardiogenic shock. Cardiac magnetic resonance imaging demonstrated extensive myocardial fibrosis, and autopsy revealed diffuse lymphocytic infiltration. Postmortem testing confirmed positivity for anti-Kv1.4 antibodies. Discussion This case highlights the potentially fatal course of suspected anti-Kv1.4 antibody-associated inflammatory myocardial disease despite an initial favourable response to immunosuppressive therapy. It illustrates the diagnostic and therapeutic challenges of distinguishing immune-mediated progression from other causes of myocardial injury and implies the need for individualised long-term management strategies.
Reference Key
openalex_W7225086091 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tsukasa Kato, Ken Miura, Hiroyuki Watanabe
Are you one of these authors? Claim your profile
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag819
URL
https://doi.org/10.1093/ehjcr/ytag819
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.